DOB + Flashcards

1
Q

question

A

answer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pulmonary etiologies of DOB

A
COPD
asthma
restrictive lung disorder
hereditary lung disorder
pneumonia
pneumo-thorax
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

cardiac etiologies of DOB

A
CHF
Coronary artery disease (CAD)
MI
cardiomyopathy
valvular dysfunction
left ventricular hypertrophy
pericarditis
arrythmias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mixed cardiac/pulmonary etiology of DOB

A

chronic pulmonary emboli
pleural effusion
deconditioning
COPD with HTN and/or cor pulmonale

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

noncardiac or nonpulmonary etiology of DOB

A
metabolic disorders
pain
trauma
neuromuscular disorders
functional
cheminal exposure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

< 20 yo

asthma
COPD

A

asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

worse during night or early morning

asthma
COPD

A

asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

lung function normal between symptoms

asthma
COPD

A

asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

variable airflow limitation

asthma
COPD

A

asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CXR normal

asthma
COPD

A

asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

> 40 yo

asthma
COPD

A

COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

daily symptoms and exertional dyspnea

asthma
COPD

A

COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

persistent airflow limitation

asthma
COPD

A

COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

lung function abnormal between symptoms

asthma
COPD

A

COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CXR shows severe hyperinflation

asthma
COPD

A

COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

possible clinical features of severe asthma

A
tachypnea
tachycardia
silent chest
cyanosis
accesssory muscle use
altered consciouness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why use PEF for asthma dx

A

more convinient and cheaper than FEV1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What SpO2 level do you seek to maintain withoxygen therapy

A

92% O2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

When is ABG necessary for DOB?

A

patients with SpO2 <92% or features of life threatening asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Management of asthma accronym

A

ASTHMA

Adrenergics (beta 2 agonists - Albuterol)
Streoids
Theophylline
Hydration (IV)
Mask O2
Anticholinergics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

digital clubbing + DOB

A

COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

pursing of lips + DOB

A

COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

COPD airflow obstruction level

A

FEV1/FVC ratio <0.7 post-bronchodilator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is performed to diagnose COPD

A

spirometry, post-bronchodilator

25
COPD spirometry is performed (pre/post) bronchodilator
post bronchodilator
26
COPD exacerbations mangement
``` O2 bronchodilators (SABA with or without short-acting anticholinergics) systemic corticosteroids (40 mg prednisone per day for 5 days) ```
27
Type 1 pneumonias (2)
lobar and bronchopneumonia
28
Type 2 pneumonia (2)
CAP and HAP
29
patch consolidation usually in bases of both lungs what type of pneumonia?
bronchopneumonia
30
What is the point criteria for treatment of penumonia? Acryonym and scoring
CURB 65 ``` Confusion Uremia Respiratory Rate >30 Blood pressure low 65 yo or greater ```
31
Uses structure for classification ACCF/AHA stages of HF NYHA functional
ACCF/AHA stages of HF
32
Cardiogenic shock. Hypotension, peripheral vasoconstriction Kilip classification Stage I Stage II Stage III Stage IV
Stage IV
33
Severe HF. Frank pulmonary edema with rales Kilip classification Stage I Stage II Stage III Stage IV
Stage III
34
HF. Rales, S3 gallop and pulmonary venous hypertention Kilip classification Stage I Stage II Stage III Stage IV
Stage II
35
Acute HF management
SpO2 95-98% patent airway and FiO2 can be increased diuretics (secondary to fluid retension)
36
MC cause of dyspnea in AHF
pulmonary edema
37
In AHF, morphine induced the following
venodilation mild aterial dilation redude HR
38
In AHF, what is a potential adverse effect?
increasing need for inasive ventilation
39
reduce LV-preload and after-load wo imparing tissue perfusion nitrates sodium nitroprusside nesiritide inotropes
nitrates
40
hypertensive HF or MR, severe HR with predominantly increased after-load nitrates sodium nitroprusside nesiritide inotropes
sodium nitroprusside
41
reduce preload and after-load, increase CO wo direct inotropic effects nitrates sodium nitroprusside nesiritide inotropes
nesiritide
42
Pts with severely reduced cardic output compromised vital organ perfusion nitrates sodium nitroprusside nesiritide inotropes
inotropes
43
When are vasopressors indicated?
combination inotropic agent and fluid challenge fails to restore adequate arterial pressure and organ perfusion
44
HVS causes (increase/decrease) pCO2 which leads to (metabolic/respiratory) (alkalosis/acidosis)
HVS causes DECREASE pCO2 which leads to RESPIRATORY alkalosis
45
common ddx for HVS
acute coronary syndrome pulmonary embolism CO2 poisoning
46
HVS has (abnormal/normal) pH with (high/low) PaCO2 and a (high/low) bicarbonate level
HVS has NORMAL pH with LOW PaCO2 and a LOW bicarbonate level
47
Pharmaco therapies for HVS
benzodiazepines lorazepam (ativan) diazepam (valium) paroxetine (paxil)
48
define tachypnea
A respiratory rate greater than normal. Normal rates range from 44 cycles/min in a newborn to 14 to 18 cycles/min in adults
49
normal RR for newborn
44 cycles/min
50
normal RR for adult
14 to 18 cycles/min
51
central control - medulla oblongata - chemoreceptors
- medulla | oblongata
52
peripheral control - medulla oblongata - chemoreceptors
- chemoreceptors
53
where are the chemoreceptors that control breathing peripherally
located near the carotid bodies, and | mechanoreceptors in the diaphragm and skeletal muscles
54
what causes the perception of dyspnea
imbalance in either central or peripheral control of breathing
55
differential diagnoses for acute dyspnea
- pulmonary - cardiac - abdominal - psychogenic - metabolic or endocrine - infectious - traumatic - hematalogic - neuromuscular
56
acute dyspnea associated with normal or increased respiratory effort
- abdominal - psychogenic - metabolic or endocrine - infectious - traumatic - hematalogic
57
neuromuscular etiology is primarily associated with (increased/decreased) respiratory effort
neuromuscular etiology is primarily associated with DECREASED respiratory effort
58
most common causes of dyspnea in ER (5)
1. obstructive airway disease (asthma, COPD) 2. decompensated heart failure 3. ischemic heart disease 4. pneumonia 5. psychogenic
59
most immediately life-threatening causes of dyspnea in ER (5)
1. upper airway obstruction 2. tension pneumothorax 3. pulmonary embolism 4. neuromuscular weakness 5. fat embolism